Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial

Benjamin Diamond, Ola Landgren, Kylee Maclachlan et al.|The Lancet Haematology|2021

Cited by 95